BrCa is a complex heterogeneous disease classified into three major subtypes according to estrogen receptor (ER) or progesterone receptor (PR) expression and erb-b2 receptor tyrosine kinase 2 (ERBB2; formerly human epidermal growth factor 2, HER2) gene amplification. Here, ESR1 is linked to invasive breast carcinoma.